Cymabay Therapeutics Inc (CBAY.OQ)
CBAY.OQ on NASDAQ Stock Exchange Global Select Market
5.92USD
4:57pm BST
5.92USD
4:57pm BST
Change (% chg)
$0.19 (+3.32%)
$0.19 (+3.32%)
Prev Close
$5.73
$5.73
Open
$5.73
$5.73
Day's High
$5.92
$5.92
Day's Low
$5.73
$5.73
Volume
31,631
31,631
Avg. Vol
310,379
310,379
52-wk High
$14.00
$14.00
52-wk Low
$4.82
$4.82
About
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)
Overall
| Beta: | 1.15 |
| Market Cap(Mil.): | $422.48 |
| Shares Outstanding(Mil.): | 68.70 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBAY.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 98.31 | 33.85 |
| EPS (TTM): | -1.31 | -- | -- |
| ROI: | -33.17 | 7.52 | 12.69 |
| ROE: | -33.47 | 7.94 | 17.13 |
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.✕
Estimates